An Exceedingly Rare Case of Liraglutide-Induced Liver Injury
Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the treatment of type 2 diabetes mellitus. We are reporting the second case of liraglutide-induced liver injury, with complete resolution of liver injury after discontinuation of the drug.
| Published in: | Case Reports in Gastrointestinal Medicine |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Online Access: | http://dx.doi.org/10.1155/2021/6306149 |